Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 769515, 9 pages
http://dx.doi.org/10.1155/2014/769515
Research Article

Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload

1Intensive Care Laboratory, Guangdong Province Hospital of Chinese Medicine, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, 101 Dade Road, Yuexiu District, Guangzhou 510120, China
2Department of Cardiology, The Second Clinical Medical School, Yangzhou University, Yangzhou 225001, China
3Animal Laboratory, Guangdong Province Hospital of Chinese Medicine, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
4Department of Oral and Maxillary Surgery, Stomatology Hospital of Guangzhou Medical University, Guangzhou 510140, China
5Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, OH 44272, USA

Received 10 April 2014; Revised 28 May 2014; Accepted 4 June 2014; Published 29 June 2014

Academic Editor: Ping Liu

Copyright © 2014 Jianyong Qi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. van Berlo, M. Maillet, and J. D. Molkentin, “Signaling effectors underlying pathologic growth and remodeling of the heart,” Journal of Clinical Investigation, vol. 123, no. 1, pp. 37–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Kandalam, R. Basu, L. Moore et al., “Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress,” Circulation, vol. 124, no. 19, pp. 2094–2105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Hu, S. J. Matkovich, P. A. Hecker, Y. Zhang, J. R. Edwards, and G. W. Dorn II, “Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 48, pp. 19864–19869, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. Dionyssiou, N. B. Nowacki, S. Hashemi et al., “Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle,” Journal of Molecular and Cellular Cardiology, vol. 54, no. 1, pp. 35–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Q. Liu, “Determination of isoquercitrin of compound kendir leaves tablets HPLC,” Traditional Chinese Medicine, vol. 26, pp. 3–4, 2004. View at Google Scholar
  6. Y. Xu, “Clinical observation of Apocynum tablets combined with nifedipine for treating 77 patients of essential hypertension,” Journal of Cardiovascular and Pulmonary Diseases, vol. 10, pp. 1479–1480, 2010. View at Google Scholar
  7. S. H. Wang, “Nifedipine combined with apocynum tablets for treating essential hypertension,” Asia Pacific Traditional Medicine, vol. 7, pp. 56–57, 2011. View at Google Scholar
  8. J. Y. Qi, M. Xu, Z. Z. Lu, and Y. Y. Zhang, “Differential expression of 14-3-3ε during physiological, pathological cardiac hypertrophy and chronic heart failure in mice,” Gene Therapy and Molecular Biology, vol. 13, no. 1, pp. 71–81, 2009. View at Google Scholar · View at Scopus
  9. H. Qiu, P. Lizano, L. Laure et al., “H11 kinase/heat shock protein 22 deletion impairs both nuclear and mitochondrial functions of stat3 and accelerates the transition into heart failure on cardiac overload,” Circulation, vol. 124, no. 4, pp. 406–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-Y. Qi, M. Xu, Z.-Z. Lu, and Y.-Y. Zhang, “14-3-3 inhibits insulin-like growth factor-I-induced proliferation of cardiac fibroblasts via a phosphatidylinositol 3-kinase-dependent pathway,” Clinical and Experimental Pharmacology and Physiology, vol. 37, no. 3, pp. 296–302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. P. Li, L. S. Zhao, and S. X. Cui, “Influence of Apocynum tablet on ambulatory blood pressure in elderly patients with hypertension,” Chinese Journal of Gerontology, vol. 16, pp. 3153–3154, 2011. View at Google Scholar
  12. R. Meng, Z. Pei, A. Zhang et al., “AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway,” Archives of Biochemistry and Biophysics, vol. 511, no. 1-2, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Xin, E. N. Olson, and R. Bassel-Duby, “Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair,” Nature Reviews Molecular Cell Biology, vol. 14, no. 8, pp. 529–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. Van Berlo, J. W. Elrod, B. J. Aronow, W. T. Pu, and J. D. Molkentin, “Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 30, pp. 12331–12336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Kehat, J. Davis, M. Tiburcy et al., “Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth,” Circulation Research, vol. 108, no. 2, pp. 176–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Y. Oudit and J. M. Penninger, “Cardiac regulation by phosphoinositide 3-kinases and PTEN,” Cardiovascular Research, vol. 82, no. 2, pp. 250–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Wang, B. Long, J. Zhou, and P. Li, “miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy,” The Journal of Biological Chemistry, vol. 285, no. 16, pp. 11903–11912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. H. van Berlo, B. J. Aronow, and J. D. Molkentin, “Parsing the roles of the transcription factors GATA-4 and GATA-6 in the adult cardiac hypertrophic response,” PLoS ONE, vol. 8, no. 12, Article ID e84591, 2013. View at Publisher · View at Google Scholar
  19. S. Kobayashi, K. Mao, H. Zheng et al., “Diminished GATA4 protein levels contribute to hyperglycemia-induced cardiomyocyte injury,” The Journal of Biological Chemistry, vol. 282, no. 30, pp. 21945–21952, 2007. View at Google Scholar
  20. C. Kwan, W. Zhang, S. Nishibe, and S. Seo, “A novel in vitro endothelium-dependent vascular relaxant effect of Apocynum venetum leaf extract,” Clinical and Experimental Pharmacology and Physiology, vol. 32, no. 9, pp. 789–795, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. D. H. Wu, L. W. Yang, and W. W. Su, “The progress in chemical constituents and pharmacological studies of wild chrysanthemum,” Chinese Herbal Medicine, vol. 27, pp. 142–144, 2004. View at Google Scholar
  22. J. S. Burchfield, M. Xie, and J. A. Hill, “Pathological ventricular remodeling: mechanisms: part 1 of 2,” Circulation, vol. 128, no. 4, pp. 388–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. V. B. Pillai, N. R. Sundaresan, and M. P. Gupta, “Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging,” Circulation Research, vol. 114, no. 2, pp. 368–378, 2014. View at Publisher · View at Google Scholar
  24. S. Ulm, W. Liu, M. Zi et al., “Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction,” Journal of Molecular and Cellular Cardiology, vol. 72, pp. 104–116, 2014. View at Publisher · View at Google Scholar
  25. J. D. Molkentin, “The zinc finger-containing transcription factors GATA-4, -5, and -6: ubiquitously expressed regulators of tissue-specific gene expression,” The Journal of Biological Chemistry, vol. 275, no. 50, pp. 38949–38952, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Liang, L. J. de Windt, S. A. Witt, T. R. Kimball, B. E. Markham, and J. D. Molkentin, “The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo,” The Journal of Biological Chemistry, vol. 276, no. 32, pp. 30245–30253, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Oka, M. Maillet, A. J. Watt et al., “Cardiac-specific deletion of gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability,” Circulation Research, vol. 98, no. 6, pp. 837–845, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Tenhunen, B. Sármán, R. Kerkelä et al., “Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heart,” The Journal of Biological Chemistry, vol. 279, no. 23, pp. 24852–24860, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American Heart Association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar
  30. H. Yang, F. Xie, Y. Yang, and Y. Luo, “Preparation and in vitro release characteristics of pulsed-release tablets of Apocynum venetum,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 11, pp. 1427–1430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Wu, C. X. Chen, W. L. Gu, J. P. Gao, Y. Wan, and J. Lv, “Effect of Chrysanthemum indicum on ventricular remodeling in rats,” Zhong Yao Cai, vol. 33, no. 7, pp. 1112–1115, 2010. View at Google Scholar · View at Scopus